Skip to main content

Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance.

Publication ,  Journal Article
Chen, LF; Anderson, DJ; Paterson, DL
Published in: Infect Drug Resist
2012

Klebsiella pneumoniae carbapenemases (KPCs) confer resistance to nearly all β-lactams. This broad-spectrum drug resistance mechanism has rapidly spread in the United States and is reportedly increasing elsewhere in the world. Thus, the emergence of KPC resistance is a major threat to global health. This article reviews the epidemiology and provides an overview of the dissemination of KPC-producing organisms.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Infect Drug Resist

DOI

EISSN

1178-6973

Publication Date

2012

Volume

5

Start / End Page

133 / 141

Location

New Zealand

Related Subject Headings

  • 3202 Clinical sciences
  • 3107 Microbiology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, L. F., Anderson, D. J., & Paterson, D. L. (2012). Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist, 5, 133–141. https://doi.org/10.2147/IDR.S26613
Chen, Luke F., Deverick J. Anderson, and David L. Paterson. “Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance.Infect Drug Resist 5 (2012): 133–41. https://doi.org/10.2147/IDR.S26613.
Chen LF, Anderson DJ, Paterson DL. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist. 2012;5:133–41.
Chen, Luke F., et al. “Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance.Infect Drug Resist, vol. 5, 2012, pp. 133–41. Pubmed, doi:10.2147/IDR.S26613.
Chen LF, Anderson DJ, Paterson DL. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist. 2012;5:133–141.

Published In

Infect Drug Resist

DOI

EISSN

1178-6973

Publication Date

2012

Volume

5

Start / End Page

133 / 141

Location

New Zealand

Related Subject Headings

  • 3202 Clinical sciences
  • 3107 Microbiology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences